IMMUNOTHERAPY WITH TUMOR-CELL SUB-POPULATIONS .1. ACTIVE, SPECIFIC IMMUNOTHERAPY OF L1210 LEUKEMIA

被引：0
|
作者：
KILLION, JJ
机构：
[1] UNIV OKLAHOMA,HLTH SCI CTR,DEPT RADIOL SCI,OKLAHOMA CITY,OK 73104
[2] OKLAHOMA MED RES FDN,PROGRAM CANC RES,OKLAHOMA CITY,OK 73104
来源：
CANCER IMMUNOLOGY IMMUNOTHERAPY | 1978年 / 4卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：115 / 119
页数：5
相关论文
共 50 条
  • [31] HETEROGENEOUS SENSITIVITY TO DRUGS OF TUMOR-CELL SUB-POPULATIONS ISOLATED FROM A SINGLE MAMMARY-TUMOR
    HEPPNER, GH
    DEXTER, DL
    DENUCCI, T
    MILLER, FR
    CALABRESI, P
    CLINICAL RESEARCH, 1978, 26 (03): : A536 - A536
  • [32] IMMUNOLOGICAL HETEROGENEITY OF TUMOR-CELL SUB-POPULATIONS FROM A SINGLE-MOUSE MAMMARY-TUMOR
    MILLER, FR
    HEPPNER, GH
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1979, 63 (06): : 1457 - 1463
  • [33] IMMUNOTHERAPEUTIC VALUE OF A L1210 TUMOR-CELL VACCINE DEPENDS UPON EXPRESSION OF CELL-SURFACE CARBOHYDRATES
    KILLION, JJ
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1977, 3 (02) : 87 - 91
  • [34] ACTIVE SPECIFIC IMMUNOTHERAPY OF ESTABLISHED MICROMETASTASIS - EFFECT OF CRYOPRESERVATION PROCEDURES ON TUMOR-CELL IMMUNOGENICITY IN GUINEA-PIGS
    PETERS, LC
    HANNA, MG
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1980, 64 (06) : 1521 - 1525
  • [35] EFFECT OF ACTIVE SPECIFIC INTRALYMPHATIC IMMUNOTHERAPY (ASILI) IN CANCER-PATIENTS - INDUCTION OF 2 DISTINCT T4 SUB-POPULATIONS
    RAO, VS
    WISEMAN, C
    BAKKE, A
    UDIS, B
    MCKENNA, R
    CARBERRY, J
    BOUZAGLOU, A
    SMITH, JD
    KERMAN, R
    PRESANT, C
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 283 - 283
  • [36] SUCCESSFUL CHEMO-IMMUNOTHERAPY OF MURINE L1210 LYMPHATIC-LEUKEMIA WITH CYCLOPHOSPHAMIDE AND MAFOSFAMIDE-TREATED LEUKEMIA-CELLS
    KAWALEC, M
    SKORSKI, T
    KAWIAK, J
    INVESTIGATIONAL NEW DRUGS, 1988, 6 (03) : 169 - 172
  • [37] O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE ATTENUATES TRIAZENE-INDUCED CYTOTOXICITY AND TUMOR-CELL IMMUNOGENICITY IN MURINE L1210 LEUKEMIA
    GRAZIANI, G
    FARAONI, I
    GROHMANN, U
    BIANCHI, R
    BINAGLIA, L
    MARGISON, GP
    WATSON, AJ
    ORIANDO, L
    BONMASSAR, E
    DATRI, S
    CANCER RESEARCH, 1995, 55 (24) : 6231 - 6236
  • [38] SIMULTANEOUS DEVELOPMENT OF HUMORAL AND CELLULAR TUMOR-SPECIFIC IMMUNITY AGAINST L1210 MOUSE LEUKEMIA
    KAWASHIMA, K
    ISOBE, K
    NAGASE, F
    YOKOCHI, T
    NAGURA, E
    HASEGAWA, Y
    MORISHITA, H
    YAMADA, K
    NAKASHIMA, I
    LEUKEMIA RESEARCH, 1985, 9 (07) : 935 - 939
  • [39] ACTIVE SPECIFIC IMMUNOTHERAPY WITH AN AUTOLOGOUS VIRUS-MODIFIED TUMOR-CELL VACCINE IN HUMAN RENAL-CELL CARCINOMA (RCC)
    HINKEL, A
    DERIESE, W
    ALEFELDER, J
    LAUMANN, D
    FALKENBERG, FW
    SENGE, T
    HERTLE, L
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (10) : 1719 - 1720
  • [40] ADOPTIVE IMMUNOTHERAPY IN BALB/C X DBA/2 CR F1 MICE BEARING AN IMMUNOGENIC SUBLINE OF L1210 LEUKEMIA
    NICOLIN, A
    CANTI, G
    GOLDIN, A
    CANCER RESEARCH, 1974, 34 (11) : 3044 - 3048
12345